TLE1 Antibodies

Santa Cruz Biotechnology delivers a wide array of TLE1 monoclonal antibodies for investigating TLE1 in various biological processes. TLE1 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TLE1, or Transducin-Like Enhancer of Split 1, functions as a key regulator in the Notch signaling pathway and significantly influences cellular differentiation and development. The role of TLE1 in transcriptional repression is essential for maintaining proper cellular functions and has notable implications in various diseases, including cancer. Research focusing on TLE1 continues to reveal new insights into developmental biology and potential therapeutic approaches. Scientists worldwide rely on TLE1 monoclonal antibodies to explore cellular mechanisms and pathways. Understanding TLE1's molecular interactions helps advance knowledge in both basic research and clinical applications. Santa Cruz Biotechnology monoclonal antibodies for TLE1 enable researchers to make meaningful contributions to scientific discovery and therapeutic development.